Hamilton Wealth’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-132,463
Closed -$11.7M 129
2025
Q2
$11.7M Buy
132,463
+128,785
+3,501% +$11.2M 2.61% 13
2025
Q1
$335K Sell
3,678
-41,306
-92% -$3.72M 0.08% 66
2024
Q4
$3.88M Buy
+44,984
New +$4.07M 0.94% 30

Other funds holding PPH

Hamilton Wealth's PPH Position: Q3 2025 in Review

Hamilton Wealth sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2025, closing a stake of 132,463 shares — an estimated $11.7M sold.

Hamilton Wealth first reported a position in PPH in Q4 2024 and held it in 3 quarters. The position peaked at $11.7M in Q2 2025. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.

  • Hamilton Wealth reported no remaining VanEck Pharmaceutical ETF position as of Q3 2025 after selling out during the quarter.
  • Hamilton Wealth sold 132,463 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $11.7M.
  • Hamilton Wealth first reported a position in VanEck Pharmaceutical ETF in Q4 2024 and held it in 3 quarters.
  • Hamilton Wealth's VanEck Pharmaceutical ETF position peaked at $11.7M in Q2 2025.
  • 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.

Based on Hamilton Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.